Yocell Biotechnology (Qingdao) Co., LTD

Recently, Yocell successfully completed the shipping of three sets of equipment: the YC-Nano10 high-pressure homogenizer, the LE-1 manual liposome extruder and the LE-100 manual liposome extruder.

Recently, Yocell has successfully secured a tender for a set of YC-FLEX benchtop parallel bioreactors！

This article explores the application of biological fermentation in the pharmaceutical industry. Biological fermentation boasts economic, eco-friendly and scalable strengths, and has become a key technology for manufacturing antibiotics, vitamins and other major drugs. It covers three core production stages with corresponding professional supporting equipment, alongside testing and energy-saving devices to guarantee standardized and green production. With technological upgrades, biological fermentation will further drive pharmaceutical innovation and enjoys promising development prospects.

Our company has successfully won the bid for the NexTract 025 protein purification system procurement project, gaining client recognition and strengthening its layout in the life science equipment foreign trade market.

Microfluidization high-pressure homogenization is a mainstream technology for preparing nano lipid carriers (liposome/nano emulsion). It can increase the encapsulation efficiency of Pro-Xylane to 85%~90%, control the particle size within 50~200 nm, and raise the transdermal rate by approximately 40%, which significantly enhances its stability and skin delivery efficiency.

Protein purification is a process that separates and purifies target proteins from complex mixtures by taking advantage of the differences in their physical and chemical properties. Its core objective is to obtain high-purity and highly active protein products, and it is a cornerstone technology in biological research and the biotechnology industry.